Exploring the Uses of RNAi — Gene Knockdown and the Nobel Prize
- 7 December 2006
- journal article
- other
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 355 (23) , 2391-2393
- https://doi.org/10.1056/nejmp068242
Abstract
The Nobel Prize in Physiology or Medicine was awarded this year to Andrew Fire (Stanford University School of Medicine) and Craig Mello (University of Massachusetts Medical School) for their discovery of a new form of gene silencing. Nearly 9 years ago, Fire and Mello and their colleagues reported that exposing cells of the nematode Caenorhabditis elegans to double-stranded RNA resulted in specific and efficient gene silencing.1 They also observed that double-stranded RNA is far more potent than sense or antisense RNA in silencing the gene that shares its sequence, and they dubbed the silencing process “RNA interference” (RNAi). Because RNAi . . .Keywords
This publication has 4 references indexed in Scilit:
- Therapeutic Potential of siRNA-Mediated Transcriptional Gene SilencingBioTechniques, 2006
- A loss-of-function RNA interference screen for molecular targets in cancerNature, 2006
- A TRAIL receptor-dependent synthetic lethal relationship between MYC activation and GSK3β/FBW7 loss of functionProceedings of the National Academy of Sciences, 2005
- Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegansNature, 1998